Opsin Biotherapeutics, a pioneering biomedical technology company, announced a two-year, $2.35 million Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute …
INVESTMENT
Dallas-based biotech startup MusiQ Bio, a UT Southwestern Medical Center spinoff, received a $2.59 million state grant to advance new cancer treatments. Date: 2026-09-29 dallasinnovates.com/dallas-biotech-startup-lands-2-6m-grant-to-fight-cancer/ …
Astromech, the evolutionary biology AI company that spun out of Colossal Biosciences, has closed an additional $20 million in funding. To date, the company has raised $60 million and reports …
- INVESTMENT
Forte Biosciences sells for $2.2B; Lincoln Property raises $400M – Dallas Business Journal
Dallas-based biopharmaceutical company Forte Biosciences Inc. has agreed to be acquired by Dutch pharma giant Argenx SE for $2.2 billion, according to a July 27 announcement. www.bizjournals.com/dallas/news/2026/07/27/forte-biosciences-lincoln-property-deal-wrap.html
- INVESTMENT
Dallas-Based Komen’s New $15.4M Grant Round Targets AI, Emerging Technologies, and Novel Breast Cancer Therapies » Dallas Innovates
dallasinnovates.com/dallas-based-komens-new-15-4m-grant-round-targets-ai-emerging-technologies-and-novel-breast-cancer-therapies/ Dallas-based Susan G. Komen, the world’s leading breast cancer organization, recently awarded $15.4 million in grants to breast cancer researchers on the journey to unlocking the cures for all …
- INVESTMENTNEWSRELOCATION
3 Life Sciences Companies Expand Pegasus Park Presence to Tower’s Top Floor » Dallas Innovates
dallasinnovates.com/3-life-sciences-companies-expand-pegasus-park-presence-to-towers-top-floor/ The expansions by the companies—CG Oncology, Highlander Health, and LH Capital—are “strengthening the operational bridge that moves medical breakthroughs from the lab to the marketplace,” Pegasus Park said.
https://alloytx.com/alloy-therapeutics-announces-40m-series-e-to-scale-tech-enabled-biotech-infrastructure/ Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services, today announced a $40 million Series E …
- INVESTMENT
Dallas’ Curve Biosciences Raises $40M for Its ‘Whole-Body Intelligence’ Disease Monitoring Platform
A Plano-born biotech founder has returned to North Texas to establish the headquarters for his company, Curve Biosciences, at Pegasus Park, the nationally recognized life science and biotech innovation hub …
Plano’s Argano, a pioneering global consulting firm specializing in the design and delivery of high-performance business operations with an AI-forward approach to transformation, has acquired Pharosity Consulting, Inc. Based in …
UT Southwestern Medical Center will get up to $25 million from the Advanced Research Projects Agency for Health (ARPA-H) to create fully functional, patient-specific artificial livers that could ease the …